Research Topics
| Gregory PiazzaSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combinationRanjith Shetty
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
J Thromb Thrombolysis 26:35-40. 2008..Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for venous thromboembolism (VTE). We analyzed a large US deep vein thrombosis (DVT) registry to explore the profile of patients with COPD and VTE...
Heart failure in patients with deep vein thrombosisGregory Piazza
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Am J Cardiol 101:1056-9. 2008..In conclusion, the combination of higher medical acuity, increased frequency of VTE risk factors, and low rate of VTE prophylaxis presents a "triple threat" to patients with HF...- An unusual explanation for episodic dyspneaGregory Piazza
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass. 02215, USA
Circulation 114:e485-6. 2006 - Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequentGregory Piazza
Cardiovascular Division, Beth Israel Deaconess Medical Center, 1 Deaconess Rd, Baker 4, Boston, MA 02215, USA
Chest 132:554-61. 2007..Hospitalized patients with medical illness are especially susceptible to the development of venous thromboembolism (VTE)... - Hospital costs of acute pulmonary embolismJohn Fanikos
Department of Pharmacy, Brigham and Women s Hospital, Boston, MA 02115, USA
Am J Med 126:127-32. 2013..We evaluated hospitalized patients with the primary diagnosis of pulmonary embolism. Our goal was to determine the total and component costs associated with their hospital care... 
Venous thromboembolism in patients with chronic obstructive pulmonary diseaseGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Am J Med 125:1010-8. 2012..Our aim was to compare the clinical characteristics, prophylaxis, treatment, and outcomes of venous thromboembolism in patients with and without previously diagnosed chronic obstructive pulmonary disease...- Venous thromboembolism in patients with symptomatic atherosclerosisGregory Piazza
Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
Thromb Haemost 106:1095-102. 2011..Despite a high frequency of comorbid conditions contributing to the risk of VTE, we observed a low rate of thromboprophylaxis in patients with symptomatic atherosclerosis... - Deep vein thrombosis in patients with chronic kidney diseaseH Leon Daneschvar
Cardiovascular Medicine Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Thromb Haemost 99:1035-9. 2008..2% vs. 38.0%, p = 0.06). Future studies of DVT in CKD patients should explore novel strategies for improving prophylaxis utilization and the detection of DVT in this special population... - Patient education program for venous thromboembolism prevention in hospitalized patientsGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Am J Med 125:258-64. 2012..We conducted a prospective cohort study to determine whether a patient education program would improve medication adherence to clinician-ordered injectable prophylactic anticoagulation... - Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital dischargeJohn Fanikos
Department of Pharmacy, Brigham and Women s Hospital, Boston, MA, USA
Am J Med 124:1143-50. 2011.... - Long-term complications of medical patients with hospital-acquired venous thromboembolismJohn Fanikos
Department of Pharmacy, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Thromb Haemost 102:688-93. 2009..These VTE complications would be reduced by more than half with universal thromboprophylaxis. Further efforts should focus on improving VTE prophylaxis utilisation... - Submassive pulmonary embolismGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
JAMA 309:171-80. 2013..Determination of the optimal duration of anticoagulation and lifestyle modification to reduce overall cardiovascular risk are critical components of the long-term therapy of patients with acute PE... - Venous thromboembolic events in hospitalised medical patientsGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Thromb Haemost 102:505-10. 2009..The number of VTE-related events would be halved with universal thromboprophylaxis. Further efforts focused on improving VTE prevention strategies in hospitalised medical patients are warranted... - Adherence to pharmacological thromboprophylaxis orders in hospitalized patientsJohn Fanikos
Department of Pharmacy, Brigham and Women s Hospital, Boston, MA 02115, USA
Am J Med 123:536-41. 2010..Our goals were to determine which strategy demonstrated the best adherence in terms of timing and frequency of dose administration, and to determine reasons for ordered heparin not being administered... - Venous thromboembolism in patients with diabetes mellitusGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Am J Med 125:709-16. 2012..Our aim was to compare clinical characteristics, prophylaxis, treatment, and outcomes of venous thromboembolism in patients with and without previously diagnosed diabetes... - Hospital budget implications of substituting dabigatran for warfarin in an anticoagulation serviceJulie K Atay
Department of Pharmacy, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Clin Appl Thromb Hemost 18:181-4. 2012..This was comprised of $856,842 for labor, $473,658 for INR testing, and $54,994 for the drug cost of warfarin. Substitution will result in increased expense due to drug cost... - Anticoagulation-associated adverse drug eventsGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Am J Med 124:1136-42. 2011..We performed a 5-year retrospective study at Brigham and Women's Hospital to determine clinical characteristics, types, root causes, and outcomes of anticoagulant-associated ADEs... - Acute pulmonary embolism: part II: treatment and prophylaxisGregory Piazza
Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Circulation 114:e42-7. 2006 - Fibrinolysis for acute pulmonary embolismGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Vasc Med 15:419-28. 2010.... - Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levelsSteven Baroletti
Department of Pharmacy, MetroWest Medical Center, Framingham, MA, USA
Am J Med 125:44-9. 2012..An enzyme-linked immunosorbent assay detects anti-PF4/heparin antibodies to support a suspected clinical diagnosis of heparin-induced thrombocytopenia. The utility of quantitative enzyme-linked immunosorbent assay results is uncertain... - Venous thromboembolism in heart failure: preventable deaths during and after hospitalizationGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass, USA
Am J Med 124:252-9. 2011..Our aim was to compare the clinical characteristics, prophylaxis, treatment, and outcomes of patients with venous thromboembolism with and without heart failure... - Pulmonary embolism in heart failureGregory Piazza
Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA
Circulation 118:1598-601. 2008 - Deep vein thrombosis in orthopedic surgeryMarcella Calfon
Department of Medicine, Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston Massachusetts, USA
Clin Appl Thromb Hemost 15:512-6. 2009..In conclusion, despite having fewer comorbid conditions, orthopedic patients with deep vein thrombosis remain particularly vulnerable to calf deep vein thrombosis. Rates of venous thromboembolism prophylaxis were inadequate... - Deep-vein thrombosis in the elderlyGregory Piazza
Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, 1 Deaconess Road, Boston, MA 02215, USA
Clin Appl Thromb Hemost 14:393-8. 2008..Diagnosis can present a challenge because typical deep-vein thrombosis symptoms may be absent. Fewer than 50% of elderly patients with deep-vein thrombosis had received any venous thromboembolism prophylaxis... - Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Circulation 119:2196-201. 2009.... - Physician alerts to prevent venous thromboembolismGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Thromb Thrombolysis 30:1-6. 2010..In this review article, we discuss decision support strategies for improving VTE prevention during hospitalization and at the time of discharge... - Acute pulmonary embolism: part I: epidemiology and diagnosisGregory Piazza
Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Circulation 114:e28-32. 2006 - Intracavitary pressure wire and intravascular ultrasound for the evaluation of combined symmetric hypertrophic cardiomyopathy and aortic stenosis in a patient with dyspnea and syncope: treatment with ethanol septal ablationJoanna J Wykrzykowska
Cardiovascular Division, Beth Israel Deaconess Medical Center, One Deaconess Road, Baker 4, Boston, MA 02215, USA
J Invasive Cardiol 20:E171-3. 2008..After establishing that the majority of outflow obstruction was dynamic and related to the hypertrophic cardiomyopathy, the patient underwent successful ethanol septal ablation... - Underutilization of thromboprophylaxis in patients with heart failure. Dr. Gregory Piazza is interviewed by Dr. George LundbergGregory Piazza
Medscape J Med 10:106. 2008